Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma
暂无分享,去创建一个
Hongbing Shen | W. Tan | Chen Wu | D. Lin | Zhibin Hu | Weihua Jia | Yifeng Zhou | Dianke Yu | Kan Zhai | Jiang Chang | Y. Qiao | Yixin Zeng | Yuling Zhou | Lixuan Wei | T. Tong | Ming-Rong Wang | Dong Li | D. Lin | Meng-han Wang | Menghan Wang | W. Tan
[1] K. Chow,et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors , 1999, American Journal of Gastroenterology.
[2] U. Lehmann,et al. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. , 2001, Methods.
[3] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[4] R. Nicholson,et al. The LZT proteins; the LIV-1 subfamily of zinc transporters. , 2003, Biochimica et biophysica acta.
[5] L. Zhang,et al. Operable squamous esophageal cancer: Current results from the East , 1994, World Journal of Surgery.
[6] R. Nicholson,et al. Zinc transporter LIV-1: a link between cellular development and cancer progression , 2004, Trends in Endocrinology & Metabolism.
[7] T. Hirano,et al. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer , 2004, Nature.
[8] G. Abecasis,et al. A note on exact tests of Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.
[9] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[10] K. Taylor,et al. LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway. , 2007, Biochemical and biophysical research communications.
[11] M. Kasuga,et al. Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese , 2007, American journal of clinical oncology.
[12] D. Radisky,et al. Epithelial-mesenchymal transition and the stem cell phenotype. , 2008, Cell stem cell.
[13] F. Motoi,et al. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells. , 2009, International journal of oncology.
[14] K. Taylor,et al. Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach , 2009, Molecular Cancer Therapeutics.
[15] N. Altorki,et al. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. , 2009, The Annals of thoracic surgery.
[16] Y. Kamatani,et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. , 2009, Gastroenterology.
[17] M. Beckmann,et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. , 2010, Journal of the National Cancer Institute.
[18] L. Butterfield,et al. Zinc in innate and adaptive tumor immunity , 2010, Journal of Translational Medicine.
[19] Jian-ming Wang,et al. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma , 2011, BMC Cancer.
[20] Min Dai,et al. Cancer trends in China. , 2010, Japanese journal of clinical oncology.
[21] A. Butte,et al. Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association , 2010, PloS one.
[22] V. López,et al. Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells. , 2010, Experimental cell research.
[23] T. Oyama,et al. EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma. , 2010, Frontiers in bioscience.
[24] Bin Liu,et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.
[25] Hongbing Shen,et al. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. , 2010, Cancer research.
[26] N. Hu,et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.
[27] A. Kuwahara,et al. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma , 2010, Journal of experimental & clinical cancer research : CR.
[28] W. Dinjens,et al. Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus , 2010, Journal of Gastrointestinal Surgery.
[29] N. Altorki,et al. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. , 2010, The Journal of thoracic and cardiovascular surgery.
[30] C. Kimchi-Sarfaty,et al. Understanding the contribution of synonymous mutations to human disease , 2011, Nature Reviews Genetics.
[31] Jian Gu,et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. , 2011, Journal of the National Cancer Institute.
[32] Lixin Wei,et al. Epithelial-Mesenchymal Transition in tumor microenvironment , 2011, Cell & Bioscience.
[33] R. Vessella,et al. LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling , 2011, PloS one.
[34] Yusuke Nakamura,et al. A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303 , 2011, Clinical Cancer Research.
[35] Zhou Wang,et al. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer. , 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[36] Hongbing Shen,et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations , 2011, Nature Genetics.
[37] Peter Kraft,et al. Genome-wide association study of survival in patients with pancreatic adenocarcinoma , 2012, Gut.
[38] N. Hayward,et al. Helicobacter pylori infection and the risks of Barrett's oesophagus: A population‐based case–control study , 2012, International journal of cancer.
[39] S. Natsugoe,et al. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy , 2013, International Journal of Clinical Oncology.
[40] R. Klein,et al. A Replication Study and Genome-Wide Scan of Single-Nucleotide Polymorphisms Associated with Pancreatic Cancer Risk and Overall Survival , 2012, Clinical Cancer Research.
[41] J. Liu,et al. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[42] A. Thrift,et al. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival , 2012, International journal of cancer.
[43] Wei Zheng,et al. Novel genetic markers of breast cancer survival identified by a genome-wide association study. , 2012, Cancer research.
[44] Bin Liu,et al. : Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and , 2010 .